Search
Rivastigmine
go.drugbank.com/drugs/DB00989ApprovedInvestigationalRivastigmine is a cholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase. … Rivastigmine is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer's type.
Synonyms: Rivastigmine, RivastigminaSalts: Rivastigmine tartrateLinoleic acid
go.drugbank.com/drugs/DB14104ApprovedSynonyms: LAMixtures: Gla 130 Primrose Oil, Bio-efa Borage Gla 90 CapEucommia ulmoides bark
go.drugbank.com/drugs/DB14259InvestigationalEucommia ulmoides bark is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Synonyms: Du Zhong, Du Zhong BarkSage oil
go.drugbank.com/drugs/DB11199ApprovedNutraceutical*Salvia officinalis* is a common sage and a member of the genus *Salvia*, that includes aromatic and perennial plants with flowers.
Synonyms: Sage oil franceDuvakitug
go.drugbank.com/drugs/DB19444InvestigationalDuvakitug is under investigation in clinical trial NCT05668013 (A Study to Evaluate the Long-term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease).
Synonyms: Du vakitug, Immunoglobulin G1 [de-449-lysine], anti-(human tumor necrosis factor superfamily protein TNFSF15) (human monoclonal TEV-48574 γ1-chain), disulfide with human monoclonal TEV-48574 λ-chain, dimerRivastigmine Action Pathway (new)
smpdb.ca/view/SMP0126688Drug actionRivastigmine is a cholinesterase inhibitor used in the treatment of symptoms of dementia in Alzheimer's and Parkinson's.
Rivastigmine Predicted Metabolism Pathway
smpdb.ca/view/SMP0174555MetabolicMetabolites of Rivastigmine are predicted with biotransformer.
Theophylline
go.drugbank.com/drugs/DB00277ApprovedInvestigationalMechanistically, theophylline acts as a phosphodiesterase inhibitor, adenosine receptor blocker, and histone deacetylase activator. … A methylxanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities.
Mixtures: I D M Expectorant Tab, TUSBRON-A JARABECategories: Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index